Condition

Type-2 Diabetes Mellitus

ClinicalTrials.gov condition label

Clinical trials9

Recruiting1

Common interventions14

Lead sponsors shown9

Clinical trials

9 shown

A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)NCT07355270 · 2026-04-01

Stanford Kids CAMP StudyNCT05380817 · 2022-07-01

Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 DiabetesNCT02693392 · 2016-01-17

Loop Duodenal Switch Surgery in Morbidly Obese PatientsNCT02671331 · 2016-01-01

Ticagrelor Versus Clopidogrel in Type 2 Diabetic PatientsNCT01823510 · 2013-07-01

Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by MetforminNCT01766778 · 2013-05-13

Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb IschemiaNCT01818310 · 2012-09-01

Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes MellitusNCT01472614 · 2011-09-01

Risk Prediction in Type II Diabetics With Ischemic Heart DiseaseNCT01422057 · 2010-01-01

Common interventions

Clopidogrel + AspirinDRUG1 DLBS3233DRUG1 Fenugreek Seed extractDIETARY_SUPPLEMENT1 Group A: IntramuscularBIOLOGICAL1 Group B: IntraarterialBIOLOGICAL1 Group C: IntravenousBIOLOGICAL1 Group D: Surgical endovascular treatment with maximum medicamentous treatmentPROCEDURE1 LAF237 (vildagliptin)DRUG1 Loop duodenal switchPROCEDURE1 MetforminDRUG1 Oral hypoglycemic agents (pre-specified) [Metformin, Sulfonylurea]DRUG1 Remote Monitoring ProgramOTHER1 RF Vapor AblationDEVICE1 Ticagrelor + AspirinDRUG1

Leading sponsors

All India Institute of Medical Sciences, Bhubaneswar1 Aqua Medical, Inc.1 Dexa Medica Group1 Juan J Badimon1 Medical College of Wisconsin1 Novartis Pharmaceuticals1 Stanford University1 Thebiosignals.com1 University Hospital Ostrava1

Trial status mix

COMPLETED5

UNKNOWN2

RECRUITING1

TERMINATED1

Phase mix

NA3

PHASE32

PHASE42

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.